| P2093 | author name string | Dana E Selley | |
| | James J Burston | |
| | Laura J Sim-Selley | |
| | Jenny L Wiley | |
| | Daniel R Howard | |
| | Seth H Kendler | |
| P2860 | cites work | Mechanism of Action of Atypical Antipsychotic Drugs and the Neurobiology of Schizophrenia | Q22241430 |
| | Endocannabinoid signalling in the blood of patients with schizophrenia | Q24800061 |
| | A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 |
| | CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia | Q28206825 |
| | The pharmacology of cannabinoid receptors and their ligands: an overview | Q28304279 |
| | The adolescent brain and age-related behavioral manifestations | Q29618654 |
| | Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk? | Q33211909 |
| | Gender differences in dopaminergic function in striatum and nucleus accumbens | Q33791869 |
| | Atypical antipsychotics: mechanism of action. | Q33957716 |
| | Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction | Q34415424 |
| | Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs | Q34520933 |
| | The role of sex hormones in psychopathology: focus on schizophrenia | Q34539713 |
| | Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. | Q34602111 |
| | Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis | Q34631075 |
| | The CB1 cannabinoid receptor can sequester G-proteins, making them unavailable to couple to other receptors | Q38319183 |
| | Sex and schizophrenia | Q39827054 |
| | Brain neurotransmitter receptors after long-term haloperidol: Dopamine, acetylcholine, serotonin, α-noradrenergic and naloxone receptors | Q40130681 |
| | Dopamine activation of endogenous cannabinoid signaling in dorsal striatum | Q41646203 |
| | Subchronic haloperidol increases CB(1) receptor binding and G protein coupling in discrete regions of the basal ganglia | Q42484267 |
| | Haloperidol, but not clozapine, produces dramatic catalepsy in delta9-THC-treated rats: possible clinical implications. | Q43263219 |
| | Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use. | Q43581230 |
| | Signal transduction interactions between CB1 cannabinoid and dopamine receptors in the rat and monkey striatum. | Q43621342 |
| | Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain. | Q43873792 |
| | Chronic heroin self-administration desensitizes mu opioid receptor-activated G-proteins in specific regions of rat brain. | Q44331908 |
| | delta9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors | Q44345904 |
| | Differential regulation of the endocannabinoids anandamide and 2-arachidonylglycerol within the limbic forebrain by dopamine receptor activity | Q44478915 |
| | D2 dopamine receptors modulate Galpha-subunit coupling of the CB1 cannabinoid receptor | Q44666474 |
| | Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. | Q44723162 |
| | Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia | Q44748286 |
| | Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms | Q45049153 |
| | Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs | Q45084407 |
| | Clozapine decreases [3H] CP 55940 binding to the cannabinoid 1 receptor in the rat nucleus accumbens. | Q46581750 |
| | Sex differences in neurochemical effects of dopaminergic drugs in rat striatum | Q46764294 |
| | Gender differences in schizophrenia | Q48020725 |
| | Differential effects of treatment with typical and atypical antipsychotic drugs on adenylyl cyclase and G proteins | Q48095200 |
| | Chronic haloperidol does not alter G protein alpha-subunit levels in rats | Q48235220 |
| | The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D1, D2, D3, 5HT2A and muscarinic receptors | Q48278659 |
| | Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids | Q48383234 |
| | Effects of chronic treatment of haloperidol and clozapine on levels of G-protein subunits in rat striatum | Q48587996 |
| | Delta 9-tetrahydrocannabinol enhances presynaptic dopamine efflux in medial prefrontal cortex | Q48859883 |
| | Cannabinoid and dopamine interaction in rodent brain: effects on locomotor activity. | Q49059668 |
| | Cannabis use and outcome of recent onset psychosis | Q57403352 |
| | Dose-catalepsy response to haloperidol in rat: effects of strain and sex | Q67993190 |
| | Changes in G protein levels in the hippocampus and the striatum of rat brain after chronic treatment with haloperidol and sulpiride | Q70921112 |
| | Chronic treatment with antipsychotic drugs does not alter G protein alpha or beta subunit levels in rat brain | Q73169001 |
| | Loss of cannabinoid-stimulated guanosine 5'-O-(3-[(35)S]Thiotriphosphate) binding without receptor down-regulation in brain regions of anandamide-tolerant rats | Q73194571 |
| P433 | issue | 7 | |
| P921 | main subject | pharmacology | Q128406 |
| P304 | page(s) | 1183-1190 | |
| P577 | publication date | 2008-07-30 | |
| P1433 | published in | Neuropharmacology | Q15332439 |
| P1476 | title | Antipsychotic-induced alterations in CB1 receptor-mediated G-protein signaling and in vivo pharmacology in rats | |
| P478 | volume | 55 | |